Connect Biopharma Holdings Limited

Connect Biopharma Holdings Limitedverified

CNTB

Price:

$1.435

Market Cap:

$79.07M

Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for the treatment of inflammatory allergic diseases, such as atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps. Its products also comprise CBP-307, a small molecule modulator of sphingosine 1-phosphate receptor 1, a regulator of T cell mobilization out of lymph nodes into the periphery that is in Phase II for the treatment of autoimmu...[Read more]

Industry

Biotechnology

IPO Date

2021-03-19

Stock Exchange

NASDAQ

Ticker

CNTB

The Enterprise Value as of June 2024 (TTM) for Connect Biopharma Holdings Limited (CNTB) is -26469261.00

According to Connect Biopharma Holdings Limited’s latest financial reports and current stock price. The company's current Enterprise Value is -26469261.00. This represents a change of -55.89% compared to the average of -60001757.41 of the last 4 quarters.

Connect Biopharma Holdings Limited (CNTB) Historical Enterprise Value (quarterly & annually)

How has CNTB Enterprise Value performed in the past?

The mean historical Enterprise Value of Connect Biopharma Holdings Limited over the last ten years is 2.41B. The current -26469261.00 Enterprise Value has changed -209.81% with respect to the historical average. Over the past ten years (40 quarters), CNTB's Enterprise Value was at its highest in in the September 2023 quarter at 0. The Enterprise Value was at its lowest in in the June 2021 quarter at -2023949000.00.

Quarterly (TTM)
Annual

Average

2.41B

Median

795.64K

Minimum

-218187405.96

Maximum

6.88B

Connect Biopharma Holdings Limited (CNTB) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Connect Biopharma Holdings Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual Enterprise Value = 6.88B

Minimum Annual Increase = -27522.99%

Minimum Annual Enterprise Value = -218187405.96

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2023-105542000.00-51.63%
2022-218187405.96-27522.99%
2021795.64K-99.99%
20205.50B-20.04%

Connect Biopharma Holdings Limited (CNTB) Average Enterprise Value

How has CNTB Enterprise Value performed in the past?

The current Enterprise Value of Connect Biopharma Holdings Limited (CNTB) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-107644589.73

5-year avg

2.41B

10-year avg

2.41B

Connect Biopharma Holdings Limited (CNTB) Enterprise Value vs. Peers

How is CNTB’s Enterprise Value compared to its peers?

Connect Biopharma Holdings Limited’s Enterprise Value is less than Assembly Biosciences, Inc. (0), less than Neoleukin Therapeutics, Inc. (78.15M), less than Instil Bio, Inc. (-6333315.00), less than CytomX Therapeutics, Inc. (147.25M), less than Achilles Therapeutics plc (78.00M), greater than NextCure, Inc. (-71130889.00), less than Nuvation Bio Inc. (34.98M), less than Ovid Therapeutics Inc. (715.48M), less than null (72.55M),

CompanyEnterprise ValueMarket cap
0$94.96M
78.15M$8.20M
-6333315.00$66.93M
147.25M$101.31M
78.00M$36.98M
-71130889.00$46.71M
34.98M$746.46M
715.48M$57.63M
72.55M$0

Build a custom stock screener for Connect Biopharma Holdings Limited (CNTB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Connect Biopharma Holdings Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Connect Biopharma Holdings Limited (CNTB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Connect Biopharma Holdings Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Connect Biopharma Holdings Limited's Enterprise Value?

What is the highest Enterprise Value for Connect Biopharma Holdings Limited (CNTB)?

What is the 3-year average Enterprise Value for Connect Biopharma Holdings Limited (CNTB)?

What is the 5-year average Enterprise Value for Connect Biopharma Holdings Limited (CNTB)?

How does the current Enterprise Value for Connect Biopharma Holdings Limited (CNTB) compare to its historical average?